Posts

PhD studentship in Virtual Human Cardiovascular Modelling & Simulation

The Centre for Computational Science (CCS) of University College London (UCL) is offering a fully-funded studentship to a highly motivated candidate to start in September 2020. The studentship will cover tuition fees at UK/EU rate plus a maintenance stipend of £17,285 (tax free) per annum for three years. The post-holder will work primarily on scientific…

The World’s Fastest Computer to Join Fight Against COVID-19

In our previous blog posts we have highlighted in the work of the Argonne National Laboratory (ANL) and Barcelona Supercomputing Center (BSC) that High Performance Computing (HPC) resources are an invaluable research tool. Much like their counterparts and colleagues around the world, Japan’s top scientists are now refocusing and accelerating their research efforts towards addressing…

Cardiotoxicity: Supercomputer-based in silico studies by CompBioMed Core Partners aiming to make COVID-19 treatment safer for the heart

The use of certain drugs can disturb the rhythm at which hearts beat.  This disruption can have toxic effects on the heart, which are particularly dangerous for those with underlying medical conditions.  Two drugs which are known to have proarrhythmic effects are the antimalarial drugs azithromycin and hydroxychloroquine. Azithromycin and hydroxychloroquine are thought to be…

3-year PhD studentship in the simulation of chaotic systems

The Centre for Computational Science (CCS) of University College London (UCL) in collaboration with CBK Sci Con are offering a fully-funded studentship to a highly motivated candidate to start in September 2020. The studentship will cover tuition fees at UK/EU rate plus a maintenance stipend of £17,285 (tax free) per annum for three years. The…

Repurposing Existing Drugs in the Fight Against COVID-19

The use of existing pharmaceutical to treat COVID-19 has several potential benefits over the development of new drugs from the group up, not least that much shorter clinical trials would be needed and production on industrial scales has already been realised in many cases. Andrew Potterton, a PhD student at UCL and Evotec, described to…

Coronavirus Resources Across CompBioMed

Here at CoronaBlog, where we will be providing regular news and updates on the research activities of the CompBioMed members, their collaborators, and the wider scientific community, we have established several other resources to provide information and aid in the COVID-19 research efforts: CompBioMed and Coronavirus provides an overview of the current CompBioMed activities, highlighting the…

Introducing the CoronaBlog

The ongoing coronavirus pandemic is having a profound impact on how we go about our day to day lives and is dominating world news and conversation (conducted from the recommended social distances, or preferably via video chat or social media).  Since the outbreak was identified in Hubei Province, China in late December last year, the…

CompBioMed and Coronavirus

CompBioMed is active in a vast international consortium across Europe and USA working on urgent coronavirus research. Heading CompBioMed’s efforts in this collaboration is Prof Peter Coveney and the Centre for Computational Science (CCS) at University College London (UCL), together with Leibniz Rechenzentrum (LRZ) and Gauss Centre for Supercomputing (GCS) Director Prof Dieter Kranzlmüller. GCS@LRZ’s…